# Metabolic and bariatric surgery versus glucagon-like peptide-1 receptor agonist therapy: A comparison of cardiovascular outcomes in patients with obesity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/metabolic-and-bariatric-surgery-versus-glucagon-like-peptide-1-receptor-agonist/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Muhammad Soban Arif Maan,Amir Humza Sohail,Samia Aziz Sulaiman,Linta Mansoor,Ethan M. Cohen,Ayowumi A. Adekolu,Salim Abunnaja,Nova Szoka,Lawrence Tabone,Shyam Thakkar,Shailendra Singh |
| Citations | 12 |
| DOI | 10.1016/j.amjsurg.2025.116242 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4407264134 |
| PMID | 39965476 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Ethan M. Cohen](https://scholariq.org/researchers/ethan-m-cohen/)

## Paper journal

- [The American Journal of Surgery](https://scholariq.org/journals/the-american-journal-of-surgery/)

## Paper primary topic

- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

## Paper topics

- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.